Subretinal Hyperreflective Material (SHRM) as biomarker of activity in Exudative and Non- exudative inflammatory choroidal neovascularization

References

• Weber ML, Heier JS. Choroidal neovascularization secondary to myopia, infection and inflammation. Dev Ophthalmol. 2016;55:167–175. doi:10.1159/000431194.
   PubMedGoogle Scholar
• Agarwal A, Invernizzi A, Singh RB, et al. An update on inflammatory choroidal neovascularization: epidemiology, multimodal imaging, and management. J Ophthalmic Inflamm Infect. 2018;8(1):13.doi:10.1186/s12348-018-0155-6.
   PubMed Web of Science ®Google Scholar
• Bansal R, Bansal P, Gupta A, et al. Diagnostic challenges in inflammatory choroidal neovascular membranes. Ocul Immunol Inflamm. 2017;25(4):554–562.doi:10.3109/09273948.2016.1160128.
   PubMed Web of Science ®Google Scholar
• Kedhar SR, Thorne JE, Wittenberg S, Dunn JP, Jabs DA. Multifocal choroiditis with panuveitis and punctate inner choroidopathy: comparison of clinical characteristics at presentation. Retina Phila Pa. 2007;27(9):1174–1179. doi:10.1097/IAE.0b013e318068de72.
   PubMed Web of Science ®Google Scholar
• Levison AL, Baynes KM, Lowder CY, Kaiser PK, Srivastava SK. Choroidal neovascularisation on optical coherence tomography angiography in punctate inner choroidopathy and multifocal choroiditis. Br J Ophthalmol. 2017;101(5):616–622. doi:10.1136/bjophthalmol-2016-308806.
   PubMed Web of Science ®Google Scholar
• Rao NA, Gupta A, Dustin L, et al. Frequency of distinguishing clinical features in Vogt-Koyanagi-Harada disease. Ophthalmology. 2010;117(3):591–599, 599.e1.doi:10.1016/j.ophtha.2009.08.030.
   PubMed Web of Science ®Google Scholar
• Yang P, Ren Y, Li B, Fang W, Meng Q, Kijlstra A. Clinical characteristics of Vogt-Koyanagi-Harada syndrome in Chinese patients. Ophthalmology. 2007;114(3):606–614. doi:10.1016/j.ophtha.2006.07.040.
   PubMed Web of Science ®Google Scholar
• Read RW. Vogt-Koyanagi-Harada disease. Ophthalmol Clin N Am. 2002;15(3):333–341, vii. doi:10.1016/s0896-1549(02)00025-1.
   PubMedGoogle Scholar
• Ahn SJ, Park SH, Lee BR. Multimodal imaging including optical coherence tomography angiography in serpiginous choroiditis. Ocul Immunol Inflamm. 2017;25(2):287–291. doi:10.1080/09273948.2017.1288824.
   PubMed Web of Science ®Google Scholar
• Nazari Khanamiri H, Rao NA. Serpiginous choroiditis and infectious multifocal serpiginoid choroiditis. Surv Ophthalmol. 2013;58(3):203–232. doi:10.1016/j.survophthal.2012.08.008.
   PubMed Web of Science ®Google Scholar
• Neri P, Lettieri M, Fortuna C, Manoni M, Giovannini A. Inflammatory choroidal neovascularization. Middle East Afr J Ophthalmol. 2009;16(4):245–251. doi:10.4103/0974-9233.58422.
   PubMedGoogle Scholar
• Invernizzi A, Pichi F, Symes R, et al. Twenty-four-month outcomes of inflammatory choroidal neovascularisation treated with intravitreal anti-vascular endothelial growth factors: a comparison between two treatment regimens. Br J Ophthalmol. 2020;104(8):1052–1056.doi:10.1136/bjophthalmol-2019-315257.
   PubMed Web of Science ®Google Scholar
• Invernizzi A, Agarwal A, Di Nicola M, Franzetti F, Staurenghi G, Viola F. Choroidal neovascular membranes secondary to intraocular tuberculosis misdiagnosed as neovascular age-related macular degeneration. Eur J Ophthalmol. 2018;28(2):216–224. doi:10.5301/ejo.5001047.
   PubMed Web of Science ®Google Scholar
• Aggarwal K, Agarwal A, Sharma A, Sharma K, Gupta V, OCTA Study Group. Detection of type 1 choroidal neovascular membranes using optical coherence tomography angiography in tubercular posterior uveitis. Retina Phila Pa. 2019;39(8):1595–1606. doi:10.1097/IAE.0000000000002176.
   PubMed Web of Science ®Google Scholar
• Zicarelli F, Azzolini C, Cornish E, et al. Optical coherence tomography features of choroidal neovascularization and their correlation with age, gender and underlying disease. Retina Phila Pa. Published online October 14 2020. doi:10.1097/IAE.0000000000002984.
   Google Scholar
• Coscas GJ, Lupidi M, Coscas F, Cagini C, Souied EH. Optical coherence tomography angiography versus traditional multimodal imaging in assessing the activity of exudative age-related macular degeneration: a new diagnostic challenge. Retina Phila Pa. 2015;35(11):2219–2228. doi:10.1097/IAE.0000000000000766.
   PubMed Web of Science ®Google Scholar
• Yang J, Zhang Q, Motulsky EH, et al. Two-year risk of exudation in eyes with nonexudative age-related macular degeneration and subclinical neovascularization detected with swept source optical coherence tomography angiography. Am J Ophthalmol. 2019;208:1–11. doi:10.1016/j.ajo.2019.06.017.
   PubMed Web of Science ®Google Scholar
• Rosenfeld PJ, Shapiro H, Tuomi L, et al. Characteristics of patients losing vision after 2 years of monthly dosing in the phase III ranibizumab clinical trials. Ophthalmology. 2011;118(3):523–530.doi:10.1016/j.ophtha.2010.07.011.
   PubMed Web of Science ®Google Scholar
• Dansingani KK, Tan ACS, Gilani F, et al. Subretinal hyperreflective material imaged with optical coherence tomography angiography. Am J Ophthalmol. 2016;169:235–248. doi:10.1016/j.ajo.2016.06.031.
   PubMed Web of Science ®Google Scholar
• Willoughby AS, Ying G-S, Toth CA, et al. Subretinal hyperreflective material in the comparison of age-related macular degeneration treatments trials. Ophthalmology. 2015;122(9):1846–1853.e5.doi:10.1016/j.ophtha.2015.05.042.
   PubMed Web of Science ®Google Scholar
• Kumar JB, Stinnett S, Han JIL, Jaffe GJ. Correlation of subretinal hyperreflective material morphology and visual acuity in neovascular age-related macular degeneration. Retina Phila Pa. 2020;40(5):845–856. doi:10.1097/IAE.0000000000002552.
   PubMed Web of Science ®Google Scholar
• Pokroy R, Mimouni M, Barayev E, et al. Prognostic value of subretinal hyperreflective material in neovascular age-related macular degeneration treated with bevacizumab. Retina Phila Pa. 2018;38(8):1485–1491.doi:10.1097/IAE.0000000000001748.
   PubMed Web of Science ®Google Scholar
• Kawashima Y, Hata M, Oishi A, et al. Association of vascular versus avascular subretinal hyperreflective material with aflibercept response in age-related macular degeneration. Am J Ophthalmol. 2017;181:61–70. doi:10.1016/j.ajo.2017.06.015.
   PubMed Web of Science ®Google Scholar
• Moraes G, Fu DJ, Wilson M, et al. Quantitative analysis of optical coherence tomography for neovascular age-related macular degeneration using deep learning. Ophthalmology. Published online September 24 2020. doi:10.1016/j.ophtha.2020.09.025.
   Google Scholar
• Tang W, Guo J, Liu W, Xu G. Optical coherence tomography angiography of inflammatory choroidal neovascularization early response after Anti-VEGF treatment. Curr Eye Res. 2020 Dec;45(12):1556–1562. doi:10.1080/02713683.2020.1767790.
   PubMed Web of Science ®Google Scholar
• Neri P, Pichi F, Pirani V, Arapi I. Systemic immunosuppression is highly effective in the long-term control of inflammatory non-infectious uveitic choroidal neovascularization: a comparative study. Ocul Immunol Inflamm. 2020 April 7:1–5. Published online. doi:10.1080/09273948.2020.1727530.
   Web of Science ®Google Scholar